Skip to content
Shop Now
Search
Search
Close
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
About
Shop
Videos
Publications
Supplements
Donate
Contact
×
Home
About
Shop
Videos
Publications
Supplements
Donate
Contact
Search
Search
Close
Shop Now
Home
About
Shop
Videos
Publications
Supplements
Donate
Contact
Home
/
Publications
/ S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis
S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis
$
0.00
S1421 Safety and Efficacy of Long-Term Treatment With Lirentelimab, A Monoclonal Antibody Against Siglec-8, in Patients With Eosinophilic Gastritis and/or Duodenitis quantity
Add to cart
Category:
Publications
Related products
S160 The Role of Roseburia in COVID-19 Pathogenesis
$
0.00
Add to cart
Rapid improvement in Alzheimer’s disease symptoms following fecal microbiota transplantation: a case report
$
0.00
Add to cart
The Presence of Clostridioides difficile Strains in the Gut by Next Generation Shotgun Sequencing: Innocent Bystander or Villain?
$
0.00
Add to cart
S227 Messenger RNA SARS-CoV-2 Vaccines Affect the Gut Microbiome
$
0.00
Add to cart
Scroll To Top